Press release
Chronic Pain Market Outlook Highlights Strategic Opportunities Across The Industry
Chronic Pain Market
Chronic Pain Market Size and Forecast Through 2030
The chronic pain market is anticipated to reach a valuation of $127.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This robust increase reflects rising interest in customized pain therapies, broader adoption of bioelectronic devices, and the expansion of telehealth services focused on pain care. Additional factors propelling this growth include a heightened emphasis on alternatives to opioid treatments and significant investments in pain research initiatives. Throughout the forecast period, key trends such as multidisciplinary pain management models, increased use of neuromodulation technologies, preference for non-opioid medications, development of home-based pain care approaches, and tighter integration with digital health platforms will continue to influence the market trajectory.
The chronic pain market size has grown strongly in recent years. It will grow from $84.66 billion in 2025 to $91.67 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising incidence of neuropathic and musculoskeletal pain, wider availability of pain medications, growing clinical recognition of chronic pain, expansion of pain clinics.
Download a free sample of the chronic pain market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Notable Contributors in the Chronic Pain Market Landscape
Several prominent companies play a vital role in the chronic pain industry, including Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, dic*kinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., and Paperplane Therapeutics.
Strategic Acquisition Enhancing Chronic Pain Solutions
In a significant move in October 2024, Stryker Corporation, a US-based leader in medical technology, completed the acquisition of Vertos Medical Inc. Although financial details weren't disclosed, this deal aims to strengthen Stryker's portfolio of non-surgical treatment options for chronic lower back pain, particularly targeting lumbar spinal stenosis. Vertos Medical is recognized for its innovative device offerings in the chronic pain management space, and this acquisition also expands Stryker's reach within ambulatory surgery centers.
View the full chronic pain market report:
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Collaborative Efforts and Partnerships Shaping Chronic Pain Management
A growing trend among leading companies in the chronic pain arena involves forming strategic partnerships to implement shared savings programs that improve patient care while optimizing resources. For example, in August 2023, MOBE, a US-based digital health company, joined forces with Override Health, a provider of healthcare services. This collaboration combines MOBE's expertise in health outcomes analytics and personalized coaching with Override's virtual interdisciplinary care model, neuroplasticity-focused coaching, and peer support, offering a comprehensive approach to managing chronic pain amid fragmented healthcare systems.
Detailed Breakdown of Chronic Pain Market Segments
The chronic pain market is organized into several critical segments:
1) By Product Type: Drugs and Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, and Other Indications
3) By End User: Hospitals, Clinics, and Research Organizations
Further subcategories provide a more granular look:
- Drug types include Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, and Corticosteroids.
- Device categories cover Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat and Cold Therapy Devices, and Bioelectronic Devices.
This segmentation allows stakeholders to better understand the various components of the chronic pain market and identify opportunities for innovation and investment.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Pain Market Outlook Highlights Strategic Opportunities Across The Industry here
News-ID: 4606124 • Views: …
More Releases from The Business Research Company
Chronic Lower Back Pain Market Study Explores Industry Growth Toward $10.05 Bill …
Understanding the chronic lower back pain market reveals promising growth prospects driven by technological innovations and evolving treatment approaches. This sector is witnessing significant advancements aimed at addressing the complex needs of patients suffering from persistent back pain, with new therapies and personalized care strategies shaping its future landscape.
Projected Value and Expansion Rates in the Chronic Lower Back Pain Market
The chronic lower back pain market is set to…
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Research Reveals …
The chronic inflammatory demyelinating polyneuropathy (CIDP) market is poised for significant expansion in the coming years, driven by advancements in treatment and growing patient awareness. As the medical community continues to innovate, the market outlook suggests promising opportunities for enhanced therapies and improved patient care.
Anticipated Market Growth and Size of the CIDP Market
The CIDP market is projected to reach a value of $3.32 billion by 2030, growing at…
Chronic Cough Market Demonstrates Long-Term Growth Potential At 9.9% CAGR
The chronic cough market is positioned for significant expansion over the coming years, driven by advancements in treatment approaches and growing healthcare investments. Understanding the factors shaping this market, the key players involved, and emerging trends offers valuable insight into its future trajectory. Below is a detailed overview of the chronic cough market's size, leading companies, driving trends, and segmentation.
Projected Growth Outlook for the Chronic Cough Market Through 2030 …
Choroidal Neovascularization Market Outlook Signals Expansion To $5.98 Billion T …
The choroidal neovascularization market is on track for considerable expansion as we approach 2030. Advances in treatment options and rising awareness of eye health are setting the stage for strong growth in this specialized ophthalmic sector. Let us explore the projected market size, key players, emerging trends, and detailed segment insights shaping this industry.
Forecasted Growth and Market Size of the Choroidal Neovascularization Market
The global choroidal neovascularization market is…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
